CNS Pharmaceuticals, Inc. Due from Other Related Parties, Current
CNS Pharmaceuticals, Inc. (CNSP) had Due from Other Related Parties, Current of $132.65 thousand as of 2021-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Notes
us-gaap:DueFromOtherRelatedPartiesCurrent · last filed 2021-08-13
- 2021-06-30: Due from Other Related Parties, Current $132.65K.
- 2021-03-31: Due from Other Related Parties, Current $132.65K.
- 2020-12-31: Due from Other Related Parties, Current $0.00.
| Period end | Due from Other Related Parties, Current |
|---|---|
| 2021-06-30 | $132.65K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $132.65K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $0.00 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |